Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
---|---|---|---|---|---|---|---|---|---|
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$19→HK$19.5 | ― | 10.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$4→HK$4.2 | ― | 12.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$43.9 | ― | 0.80% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$75.37 | ― | 1.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$73→HK$75 | ― | 16.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$63→HK$67 | ― | 2.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$21.5→HK$18.4 | ― | 6.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$100→HK$120 | ― | 14.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$55 | ― | 12.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$4.7→HK$4.8 | ― | 3.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$4.1 | ― | 24.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$62.66→HK$117.81 | ― | 32.00% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$100 | ― | 11.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$17 | ― | 27.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$22.19 | ― | 9.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$20.2→HK$20.1 | ― | 24.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$14 | ― | 31.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$61.9 | ― | 0.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$17.02→HK$15.88 | ― | 0.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$58→HK$64 | ― | 3.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$62 | ― | 12.80% | Reiterated | ||||
Vesync Co., Ltd. | BUY HK$6.79 | ― | -8.00% | Reiterated | We expect the GP margin to be stable at 45%-46% in FY24E (a drop from 46.9% in FY23), as favorable factors like the depreciation of RMB will ease while the freight rate may increase mildly due to Red Sea conflicts. For NP margin, we believe it can be at around 13.5% (from 13.2% in FY23), as the operating leverage will offset the headwind in GP margin and the small increase in A&P expenses. Maintain BUY and fine-tune TP to HK$6.79. Considering the robust growth (13% sales and 16% net profit CAGR during FY23-26E), we believe its current valuation of 7x is still highly attractive. Our TP is based on 11x FY24E P/E (rolled over from 14x FY23E P/E, vs 3-year average of 12x). | ||||
Aluminum of China | BUY HK$6.1 | ― | -25.50% | Reiterated | Buy Rating Affirmed for Aluminum Corp. of China Amid Strong Q1 Performance and Promising Growth Strategies | ||||
Asymchem Laboratories (Tianjin) Co., Ltd. Class H | BUY HK$90.12→HK$83.94 | ― | -18.10% | Reiterated | Asymchem (6821:HK) PT Lowered to HK$83.94 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Asymchem (6821:HK) to HK$83.94 (from HK$90.12) while maintaining a Buy rating. | ||||
China Overseas Land & Investment | BUY HK$17.2 | ― | 0.50% | Reiterated | Analysts Have Conflicting Sentiments on These Real Estate Companies: China Overseas Land & Investment (Other OTC: CAOVF), Ascott Residence (Other OTC: ATTRF) and Independence Realty (NYSE: IRT) | ||||
Akeso, Inc. | HOLD HK$50→HK$54 | ― | -23.00% | Assigned | |||||
Innovent Biologics | BUY HK$54→HK$47 | ― | -23.00% | Assigned | Innovent Biologics (IVBXF) Receives a Buy from Bernstein | ||||
Hong Kong Exchanges & Clearing | BUY HK$322.28→HK$324.31 | ― | -1.80% | Reiterated | Hong Kong Exchange (388:HK) (HKXCY) PT Raised to HK$324.31 at Nomura/InstinetNomura/Instinet analyst Shengbo Tang raised the price target on Hong Kong Exchange (388:HK) (OTC: HKXCY) to HK$324.31 (from HK$322.28) while maintaining a Buy rating. | ||||
ASM Pacific Technology | HOLD HK$78→HK$106 | ― | -2.70% | Reiterated | ASM Pacific Technology (522:HK) (ASMVF) PT Raised to HK$106 at HSBCHSBC analyst Wern Juan Chng raised the price target on ASM Pacific Technology (522:HK) (OTC: ASMVF) to HK$106.00 (from HK$78.00) while maintaining a Hold rating. | ||||
Prada SpA | BUY HK$67→HK$70 | ― | -3.00% | Reiterated | Prada SpA (1913:HK) (PRDSY) PT Raised to HK$70 at MacquarieMacquarie analyst Linda Huang raised the price target on Prada SpA (1913:HK) (OTC: PRDSY) to HK$70.00 (from HK$67.00) while maintaining a Outperform rating. | ||||
Xiaomi | BUY HK$29.39→HK$31.24 | ― | -6.10% | Reiterated | Xiaomi Corp (1810:HK) (XIACY) PT Raised to HK$31.24 at MacquarieMacquarie analyst Eugene Hsiao raised the price target on Xiaomi Corp (1810:HK) (OTC: XIACY) to HK$31.24 (from HK$29.39) while maintaining a Outperform rating. | ||||
Great Wall Motor Co | BUY HK$13→HK$14 | ― | -16.90% | Reiterated | Buy Rating for Great Wall Motor Co. Amid Strong Q1 Profits and Promising EV Outlook | ||||
Ping An Insurance Company of China | BUY HK$52 | ― | -10.40% | Reiterated | Strong Performance and Growth Potential Underpin Buy Rating for Ping An Insurance | ||||
CNOOC Limited | BUY HK$21 | ― | -0.30% | Reiterated | |||||
Ping An Insurance Company of China | BUY HK$54.12→HK$54.41 | ― | -1.80% | Reiterated | Ping An Insurance Company of China (PIAIF) Receives a Buy from Nomura | ||||
Pop Mart International Group Limited | SELL HK$19→HK$31 | ― | -13.70% | Reiterated | Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: Kering SA (LSE: GB:0IIH), Pop Mart International Group Limited (Frankfurt: DE:735) and Scandic Hotels Group AB (Frankfurt: DE:10H) | ||||
Ping An Insurance Company of China | BUY HK$46→HK$42 | ― | -13.10% | Reiterated | Ping An Insurance (2318:HK) (PNGAY) PT Lowered to HK$42 at HSBCHSBC analyst Kailesh Mistry lowered the price target on Ping An Insurance (2318:HK) (OTC: PNGAY) to HK$42.00 (from HK$46.00) while maintaining a Buy rating. | ||||
Li Ning Company | BUY HK$24.86→HK$22.17 | ― | -8.00% | Reiterated | Maintaining Buy on Li Ning: Promising 2024 Outlook and Attractive Valuation |